Inhibrx Biosciences, Inc. (INBX)
79.00
+1.02
(+1.31%)
USD |
NASDAQ |
Dec 31, 16:00
81.00
+2.00
(+2.53%)
After-Hours: 20:00
Inhibrx Biosciences EPS Diluted (Quarterly): -2.278 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Ligand Pharmaceuticals, Inc. | 5.685 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
| Adverum Biotechnologies, Inc. | -2.029 |
| Pelthos Therapeutics, Inc. | -5.304 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -35.26M |
| Total Expenses (Quarterly) | 35.26M |
| Enterprise Value | 1.097B |
| Earnings Yield | -12.96% |
| Normalized Earnings Yield | -12.96 |